Enrolling by Invitation
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
NCT06169579
- Conditions
- Advanced Solid Tumor
- Locations
-
- the First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
- Gansu Provincial Cancer Hospital Lanzhou, Gansu, China
- the first hospital of Lanzhou University Lanzhou, Gansu, China
- Sun Yat-sen University cancer center Guangzhou, Guangdong, China